Hitoshi Fujiwara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hitoshi Fujiwara has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
- Atsushi Shiozaki
Department of Surgery, Division of Digestive Surgery, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan
25 shared publications Eigo Otsuji
Division of Digestive Surgery, Department of Surgery Kyoto Prefectural University of Medicine Kamigyoāku Kyoto Japan
19 shared publications- Hirotaka Konishi
Division of Digestive Surgery, Department of Surgery Kyoto Prefectural University of Medicine Kyoto Japan
17 shared publications Atsushi Shiozaki
Division of Digestive Surgery, Department of Surgery Kyoto Prefectural University of Medicine Kamigyoāku Kyoto Japan
15 shared publicationsKazuma Okamoto
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
14 shared publicationsYoshiaki Kuriu
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
12 shared publications
Latest Publications
- Open Access
A Totally Laparoscopic Transhiatal Approach for Esophageal Cancer During Mediastinoscopic Esophagectomy
Background: Mediastinoscopic esophagectomy is a minimally invasive approach that avoids thoracotomy and single-lung ventilation. We previously performed this procedure using hand-assisted laparoscopic surgery (HALS) and recently established a totally laparoscopic transhiatal approach. This retrospective, non-randomized study reported laparoscopic technique and compared the feasibility and surgical outcomes of these approaches. Methods: We retrospectively reviewed 262 patients who underwent radical mediastinoscopic esophagectomy using left cervical and transhiatal approaches at the Kyoto Prefectural University of Medicine between January 2020 and June 2026. HALS was performed in 202 patients and laparoscopy in 60 patients. Surgical procedures and perioperative outcomes were compared between the groups. Results: Blood loss and total operative time did not differ significantly between the groups, although the transhiatal procedure tended to require a longer operative time with laparoscopy (p = 0.09). The approach used for middle mediastinal lymphadenectomy was similar between the two groups (43% vs. 35%, p = 0.28), and the overall number of dissected lymph nodes, excluding the upper mediastinal and cervical nodes, was comparable. However, significantly more abdominal lymph nodes were dissected with laparoscopy than with HALS (17.9 vs. 15.7, p = 0.04). Laparoscopic gastric mobilization and lymph node dissection were safely performed, with no significant differences in the rate of postoperative complications or curability. Conclusions: The totally laparoscopic transhiatal technique is a feasible and safe approach for mediastinoscopic esophagectomy, with surgical outcomes comparable to those of HALS and not inferior abdominal lymph node dissection. It may be particularly advantageous for cases requiring meticulous abdominal lymphadenectomy.
Open AccessA Totally Laparoscopic Transhiatal Approach for Esophageal Cancer During Mediastinoscopic Esophagectomy
Background: Mediastinoscopic esophagectomy is a minimally invasive approach that avoids thoracotomy and single-lung ventilation. We previously performed this procedure using hand-assisted laparoscopic surgery (HALS) and recently established a totally laparoscopic transhiatal approach. This retrospective, non-randomized study reported laparoscopic technique and compared the feasibility and surgical outcomes of these approaches. Methods: We retrospectively reviewed 262 patients who underwent radical mediastinoscopic esophagectomy using left cervical and transhiatal approaches at the Kyoto Prefectural University of Medicine between January 2020 and June 2026. HALS was performed in 202 patients and laparoscopy in 60 patients. Surgical procedures and perioperative outcomes were compared between the groups. Results: Blood loss and total operative time did not differ significantly between the groups, although the transhiatal procedure tended to require a longer operative time with laparoscopy (p = 0.09). The approach used for middle mediastinal lymphadenectomy was similar between the two groups (43% vs. 35%, p = 0.28), and the overall number of dissected lymph nodes, excluding the upper mediastinal and cervical nodes, was comparable. However, significantly more abdominal lymph nodes were dissected with laparoscopy than with HALS (17.9 vs. 15.7, p = 0.04). Laparoscopic gastric mobilization and lymph node dissection were safely performed, with no significant differences in the rate of postoperative complications or curability. Conclusions: The totally laparoscopic transhiatal technique is a feasible and safe approach for mediastinoscopic esophagectomy, with surgical outcomes comparable to those of HALS and not inferior abdominal lymph node dissection. It may be particularly advantageous for cases requiring meticulous abdominal lymphadenectomy.
- 2 August 2026
- Published byĀ Springer Nature
- p. 205-217
Mediastinoscopic Esophagectomy
- Open Access
- 1 January 2026
- Published byĀ XMLinkĀ inĀ Journal of Gastric Cancer
- Vol.Ā 26 Ā (2) , 232-246
Endoscopic Features of Background Gastritis Associated With Remnant Gastric Cancer: A Multicenter Retrospective Study
Ohashi T, et al. J Gastric Cancer. 2026 Apr;26(2):232-246. https://doi.org/10.5230/jgc.2026.26.e15
- 1 January 2026
- Published byĀ XMLinkĀ inĀ Journal of Gastric Cancer
- Vol.Ā 26 Ā (2) , 232-246
Open AccessEndoscopic Features of Background Gastritis Associated With Remnant Gastric Cancer: A Multicenter Retrospective Study
Ohashi T, et al. J Gastric Cancer. 2026 Apr;26(2):232-246. https://doi.org/10.5230/jgc.2026.26.e15
- Open Access
- 16 October 2025
- Published byĀ WileyĀ inĀ Annals of Gastroenterological Surgery
- Vol.Ā 10 Ā (2) , 363-371
Minimally Invasive Esophagectomy for Esophageal Cancer: Current Evidence and Future Perspectives
Aim: Esophageal cancer is a highly aggressive malignancy with regional variations in histological subtypes. Adenocarcinoma predominates in Western countries, whereas squamous cell carcinoma is more common in Asia. Despite advances in multimodal therapy, esophagectomy remains the cornerstone of curative treatment, and the development of various minimally invasive esophagectomies (MIE) has been promoted to reduce invasiveness and complications. The status of the MIE has been outlined. Methods: A comprehensive literature review was conducted using PubMed/MEDLINE to identify relevant studies on MIE published up to June 2025. The search focused on thoracoscopic, robotāassisted, and mediastinoscopic approaches, with an emphasis on randomized trials and highāquality comparative studies. Results: Thoracoscopic MIE, especially in the prone position, demonstrated reduced pulmonary complications and shorter recovery times than open surgery, as supported by randomized trials such as TIME, MIRO, and MONET. Robotāassisted MIE (RAMIE) further enhances lymph node dissection and improves preservation of the recurrent laryngeal nerve, as demonstrated in trials such as REVATE and RAMIE. Mediastinoscopic esophagectomy via the transcervical and transhiatal approaches is emerging as a promising alternative for highārisk patients, offering favorable perioperative outcomes with reduced pulmonary complications. Further evaluation is required to determine the efficacy of lymph node dissection and the risk of recurrent laryngeal nerve damage. Conclusion: MIE, including the thoracoscopic, robotāassisted, and mediastinoscopic approaches, is evolving into an effective and less invasive alternative to open surgery. Future research should focus on conducting standardized, multicenter trials to establish optimal surgical strategies based on tumor characteristics and patientāspecific factors.
- 16 October 2025
- Published byĀ WileyĀ inĀ Annals of Gastroenterological Surgery
- Vol.Ā 10 Ā (2) , 363-371
Open AccessMinimally Invasive Esophagectomy for Esophageal Cancer: Current Evidence and Future Perspectives
Aim: Esophageal cancer is a highly aggressive malignancy with regional variations in histological subtypes. Adenocarcinoma predominates in Western countries, whereas squamous cell carcinoma is more common in Asia. Despite advances in multimodal therapy, esophagectomy remains the cornerstone of curative treatment, and the development of various minimally invasive esophagectomies (MIE) has been promoted to reduce invasiveness and complications. The status of the MIE has been outlined. Methods: A comprehensive literature review was conducted using PubMed/MEDLINE to identify relevant studies on MIE published up to June 2025. The search focused on thoracoscopic, robotāassisted, and mediastinoscopic approaches, with an emphasis on randomized trials and highāquality comparative studies. Results: Thoracoscopic MIE, especially in the prone position, demonstrated reduced pulmonary complications and shorter recovery times than open surgery, as supported by randomized trials such as TIME, MIRO, and MONET. Robotāassisted MIE (RAMIE) further enhances lymph node dissection and improves preservation of the recurrent laryngeal nerve, as demonstrated in trials such as REVATE and RAMIE. Mediastinoscopic esophagectomy via the transcervical and transhiatal approaches is emerging as a promising alternative for highārisk patients, offering favorable perioperative outcomes with reduced pulmonary complications. Further evaluation is required to determine the efficacy of lymph node dissection and the risk of recurrent laryngeal nerve damage. Conclusion: MIE, including the thoracoscopic, robotāassisted, and mediastinoscopic approaches, is evolving into an effective and less invasive alternative to open surgery. Future research should focus on conducting standardized, multicenter trials to establish optimal surgical strategies based on tumor characteristics and patientāspecific factors.
- Open Access
- 12 November 2024
- Published byĀ WileyĀ inĀ Annals of Gastroenterological Surgery
- Vol.Ā 9 Ā (3) , 546-558
Association between surgical difficulty and tumor location based on subsegments of the Glisson branches in laparoscopic liver resection
Background: Laparoscopic liver resection has a steep learning curve, and multiple difficultyāscoring systems have been proposed to support safe implementation. Though the IWATE scoring system is widely used, the rationale for its tumor location score is unclear. The objective of our study was to establish a more accurate definition of tumor location based on subsegments of the Glisson branches.Methods: We included 176 patients who underwent laparoscopic liver resection between January 2017 and February 2024, excluding those who underwent multiple or concomitant resections of other organs. Tumor location was defined by the most proximal subsegment of the Glisson branches (1sp, Spiegel; 1pc, paraācaval; 1cp, caudate process; 3a, apical; 3b, basal; 4a; 4b; 5v, ventral; 5d, dorsal; 6v; 6d; 6 L, lateral; 7v; 7d; 8v; 8d).Results: Within each segment, comparing operative time between subsegments showed significant differences, except for S1 (3a vs. 3b, p = 0.011; 4a vs. 4b, p = 0.001; 5v vs. 5d, p = 0.012; 6v vs. 6d vs. 6 L, p = 0.007; 7v vs. 7d, p = 0.003; 8v vs. 8d, p = 0.030). Blood loss significantly differed except for S1 (3a vs. 3b, p = 0.018; 4a vs. 4b, p = 0.002; 5v vs. 5d, p = 0.016; 6v vs. 6d vs. 6 L, p = 0.011; 7v vs. 7d, p = 0.013; 8v vs. 8d, p < 0.001). The incidence of postoperative complications did not differ significantly; however, hospital stay was significantly different only in S4 (4a vs. 4b, p = 0.049).Conclusions: There are significant differences in the difficulty of laparoscopic liver resection among subsegments. More detailed scoring based on subsegments may improve accuracy, and we propose a new scoring system.
- 12 November 2024
- Published byĀ WileyĀ inĀ Annals of Gastroenterological Surgery
- Vol.Ā 9 Ā (3) , 546-558
Open AccessAssociation between surgical difficulty and tumor location based on subsegments of the Glisson branches in laparoscopic liver resection
Background: Laparoscopic liver resection has a steep learning curve, and multiple difficultyāscoring systems have been proposed to support safe implementation. Though the IWATE scoring system is widely used, the rationale for its tumor location score is unclear. The objective of our study was to establish a more accurate definition of tumor location based on subsegments of the Glisson branches.Methods: We included 176 patients who underwent laparoscopic liver resection between January 2017 and February 2024, excluding those who underwent multiple or concomitant resections of other organs. Tumor location was defined by the most proximal subsegment of the Glisson branches (1sp, Spiegel; 1pc, paraācaval; 1cp, caudate process; 3a, apical; 3b, basal; 4a; 4b; 5v, ventral; 5d, dorsal; 6v; 6d; 6 L, lateral; 7v; 7d; 8v; 8d).Results: Within each segment, comparing operative time between subsegments showed significant differences, except for S1 (3a vs. 3b, p = 0.011; 4a vs. 4b, p = 0.001; 5v vs. 5d, p = 0.012; 6v vs. 6d vs. 6 L, p = 0.007; 7v vs. 7d, p = 0.003; 8v vs. 8d, p = 0.030). Blood loss significantly differed except for S1 (3a vs. 3b, p = 0.018; 4a vs. 4b, p = 0.002; 5v vs. 5d, p = 0.016; 6v vs. 6d vs. 6 L, p = 0.011; 7v vs. 7d, p = 0.013; 8v vs. 8d, p < 0.001). The incidence of postoperative complications did not differ significantly; however, hospital stay was significantly different only in S4 (4a vs. 4b, p = 0.049).Conclusions: There are significant differences in the difficulty of laparoscopic liver resection among subsegments. More detailed scoring based on subsegments may improve accuracy, and we propose a new scoring system.
- Open Access
- 26 August 2024
- Published byĀ International Institute of Anticancer ResearchĀ inĀ In Vivo
- Vol.Ā 38 Ā (5) , 2358-2363
Utility for Postoperative Respiratory Function of Transmediastinal Esophagectomy for Esophageal Carcinoma
Background/Aim: Esophagectomy for esophageal carcinoma (EC) is known to lead to deterioration of respiratory function (RF) due to thoracotomy and mediastinal lymph node dissection. This study aimed to evaluate the impact of transmediastinal esophagectomy (TME) on pulmonary function. Patients and Methods: We retrospectively analyzed the data of 102 patients with EC who underwent transthoracic esophagectomy (TTE) or TME and underwent RF tests within three months postoperatively at Kyoto Prefectural University of Medicine between 2014 and 2022. Perioperative pulmonary functions were evaluated based on vital capacity (VC) and forced expiratory volume in one second (FEV1.0). Results: Among 102 patients undergoing esophagectomy, 12 (11.8%) patients were included in the TTE group, and the remaining 90 (88.2%) patients were included in the TME group. Neoadjuvant treatments were significantly more common in the TTE group (p=0.011), with more advanced tumor stages (p=0.017). The TME group had significantly lower estimated blood loss (p=0.015). RF after esophagectomy showed a decrease in VC, and VC of predicted (%VC). The decrease rate in VC, %VC, and FEV1.0 was significantly greater in the TTE group than in the TME group. Conclusion: TME is a surgical procedure with a less severe postoperative decline in RF than TTE.
- 26 August 2024
- Published byĀ International Institute of Anticancer ResearchĀ inĀ In Vivo
- Vol.Ā 38 Ā (5) , 2358-2363
Open AccessUtility for Postoperative Respiratory Function of Transmediastinal Esophagectomy for Esophageal Carcinoma
Background/Aim: Esophagectomy for esophageal carcinoma (EC) is known to lead to deterioration of respiratory function (RF) due to thoracotomy and mediastinal lymph node dissection. This study aimed to evaluate the impact of transmediastinal esophagectomy (TME) on pulmonary function. Patients and Methods: We retrospectively analyzed the data of 102 patients with EC who underwent transthoracic esophagectomy (TTE) or TME and underwent RF tests within three months postoperatively at Kyoto Prefectural University of Medicine between 2014 and 2022. Perioperative pulmonary functions were evaluated based on vital capacity (VC) and forced expiratory volume in one second (FEV1.0). Results: Among 102 patients undergoing esophagectomy, 12 (11.8%) patients were included in the TTE group, and the remaining 90 (88.2%) patients were included in the TME group. Neoadjuvant treatments were significantly more common in the TTE group (p=0.011), with more advanced tumor stages (p=0.017). The TME group had significantly lower estimated blood loss (p=0.015). RF after esophagectomy showed a decrease in VC, and VC of predicted (%VC). The decrease rate in VC, %VC, and FEV1.0 was significantly greater in the TTE group than in the TME group. Conclusion: TME is a surgical procedure with a less severe postoperative decline in RF than TTE.
- Open Access
- 9 January 2023
- Published byĀ Springer NatureĀ inĀ Esophagus
- Vol.Ā 20 Ā (3) , 420-426
Predictors of the difficulty of transcervical subcarinal lymph node dissection for esophageal cancer
Background: Transmediastinal radical esophagectomy (TME) is a new minimally invasive approach without thoracotomy. However, the transcervical dissection of subcarinal lymph nodes (SCLN) is challenging. The shape or narrowness of the mediastinal space, particularly around the aortic arch to the tracheal bifurcation, may increase the difficulty of this procedure. The present study aimed to clarify predictors of the difficulty of transcervical SCLN dissection. Methods: Patients who underwent TME between 2016 and 2019 were included (n = 126). Four indicators, the cervical angle, carina distance, aorta distance, and sternum distance, were defined as indicators of mediastinal narrowness by 3D-CT. The relationships between the difficulty of transcervical SCLN dissection and clinicopathological features, including the above indicators, were investigated. Results: In a univariate analysis, the cervical angle (p = 0.023), aorta distance (p = 0.002), and middle thoracic tumor (p = 0.040) correlated with difficulty. The median cervical angle and aorta distance were 15° and 33 mm in difficult cases and 19° and 43 mm in easy cases, respectively. In a multivariate analysis, the short aorta distance (odds ratio: 7.96, p = 0.002) and middle thoracic tumor (odds ratio: 3.35, p = 0.042) were independent predictive factors. Conclusions: The cervical angle, aorta distance, and middle thoracic tumor may predict the difficulty of transcervical SCLN dissection. In difficult cases, a transhiatal approach should be combined for complete SCLN dissection.
- 9 January 2023
- Published byĀ Springer NatureĀ inĀ Esophagus
- Vol.Ā 20 Ā (3) , 420-426
Open AccessPredictors of the difficulty of transcervical subcarinal lymph node dissection for esophageal cancer
Background: Transmediastinal radical esophagectomy (TME) is a new minimally invasive approach without thoracotomy. However, the transcervical dissection of subcarinal lymph nodes (SCLN) is challenging. The shape or narrowness of the mediastinal space, particularly around the aortic arch to the tracheal bifurcation, may increase the difficulty of this procedure. The present study aimed to clarify predictors of the difficulty of transcervical SCLN dissection. Methods: Patients who underwent TME between 2016 and 2019 were included (n = 126). Four indicators, the cervical angle, carina distance, aorta distance, and sternum distance, were defined as indicators of mediastinal narrowness by 3D-CT. The relationships between the difficulty of transcervical SCLN dissection and clinicopathological features, including the above indicators, were investigated. Results: In a univariate analysis, the cervical angle (p = 0.023), aorta distance (p = 0.002), and middle thoracic tumor (p = 0.040) correlated with difficulty. The median cervical angle and aorta distance were 15° and 33 mm in difficult cases and 19° and 43 mm in easy cases, respectively. In a multivariate analysis, the short aorta distance (odds ratio: 7.96, p = 0.002) and middle thoracic tumor (odds ratio: 3.35, p = 0.042) were independent predictive factors. Conclusions: The cervical angle, aorta distance, and middle thoracic tumor may predict the difficulty of transcervical SCLN dissection. In difficult cases, a transhiatal approach should be combined for complete SCLN dissection.
- Open Access
- 14 June 2022
- Published byĀ Spandidos PublicationsĀ inĀ Oncology Letters
- Vol.Ā 24 Ā (2) , 1-10
Absolute lymphocyte count and Cāreactive proteināalbumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapy
Predicting the prognosis and adverse events (AEs) of nivolumab therapy for recurrent esophageal cancer is very important. The present study investigated whether a simple blood biochemical examination could be used to predict prognosis and AEs following nivolumab treatment for relapse of esophageal cancer. A total of 41 patients who received nivolumab treatment for recurrent esophageal cancer after esophagectomy were analyzed. The absolute lymphocyte count (ALC), neutrophilālymphocyte ratio (NLR), plateletālymphocyte ratio (PLR), monocyteālymphocyte ratio (MLR) and Cāreactive proteināalbumin ratio (CAR) were assessed at the time of nivolumab induction as indices that can be calculated by blood biochemical examinations alone. Median values were 1,015 for ALC, 3.401 for NLR, 242.6 for PLR, 0.458 for MLR and 0.119 for CAR, and patients were divided into two groups according to values. A high ALC, low NLR, low PLR, low MLR and low CAR were associated with a better response to nivolumab. In addition, patients with the aforementioned indices, with the exception of low PLR, or better response were more likely to develop AEs in univariate analysis. In multivariate analysis, a high ALC [odds ratio (OR): 4.857, P=0.043] and low CAR (OR: 9.099, P=0.004) were identified as independent risk factors for AEs. Survival analysis revealed that overall survival and progressionāfree survival (PFS) rates after nivolumab treatment differed significantly between the high and low groups of ALC, NLR, PLR, MLR and CAR. The multivariate analysis identified a low ALC [hazard ratio (HR): 3.710, P=0.003] and high CAR (HR: 2.953, P=0.007) as independent poor prognostic factors of PFS. In conclusion, ALC and CAR have potential as biomarkers for outcomes of recurrent esophageal cancer following nivolumab treatment.
- 14 June 2022
- Published byĀ Spandidos PublicationsĀ inĀ Oncology Letters
- Vol.Ā 24 Ā (2) , 1-10
Open AccessAbsolute lymphocyte count and Cāreactive proteināalbumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapy
Predicting the prognosis and adverse events (AEs) of nivolumab therapy for recurrent esophageal cancer is very important. The present study investigated whether a simple blood biochemical examination could be used to predict prognosis and AEs following nivolumab treatment for relapse of esophageal cancer. A total of 41 patients who received nivolumab treatment for recurrent esophageal cancer after esophagectomy were analyzed. The absolute lymphocyte count (ALC), neutrophilālymphocyte ratio (NLR), plateletālymphocyte ratio (PLR), monocyteālymphocyte ratio (MLR) and Cāreactive proteināalbumin ratio (CAR) were assessed at the time of nivolumab induction as indices that can be calculated by blood biochemical examinations alone. Median values were 1,015 for ALC, 3.401 for NLR, 242.6 for PLR, 0.458 for MLR and 0.119 for CAR, and patients were divided into two groups according to values. A high ALC, low NLR, low PLR, low MLR and low CAR were associated with a better response to nivolumab. In addition, patients with the aforementioned indices, with the exception of low PLR, or better response were more likely to develop AEs in univariate analysis. In multivariate analysis, a high ALC [odds ratio (OR): 4.857, P=0.043] and low CAR (OR: 9.099, P=0.004) were identified as independent risk factors for AEs. Survival analysis revealed that overall survival and progressionāfree survival (PFS) rates after nivolumab treatment differed significantly between the high and low groups of ALC, NLR, PLR, MLR and CAR. The multivariate analysis identified a low ALC [hazard ratio (HR): 3.710, P=0.003] and high CAR (HR: 2.953, P=0.007) as independent poor prognostic factors of PFS. In conclusion, ALC and CAR have potential as biomarkers for outcomes of recurrent esophageal cancer following nivolumab treatment.
- 24 February 2022
- Published byĀ ElsevierĀ inĀ European Journal of Surgical Oncology
- Vol.Ā 48 Ā (2) , e176-e177
Minimally Invasive Cervical Esophagectomy (MICE), radical esophagectomy and 3-field lymphadenectomy without thoracic access.
- 24 February 2022
- Published byĀ ElsevierĀ inĀ European Journal of Surgical Oncology
- Vol.Ā 48 Ā (2) , e176-e177
Minimally Invasive Cervical Esophagectomy (MICE), radical esophagectomy and 3-field lymphadenectomy without thoracic access.
- Open Access
- 23 February 2022
- Published byĀ Wolters Kluwer HealthĀ inĀ Annals of Surgery Open
- Vol.Ā 3 Ā (1) , e135
Persistent Postgastrectomy Hypoglycemia Unawareness in Patients With Gastric Cancer Unveiled by a Prospective Study
Objective: Late dumping syndrome is a common postgastrectomy complication characterized by reactive hypoglycemia. This study aimed to explore the glycemic trend in patients who underwent gastrectomy for gastric cancer and clarify its changes over time in association with postgastrectomy symptoms. Summary Background Data: Changes over time in glycemic trend in association with postgastrectomy symptoms have not been evaluated. Methods: We conducted a prospective study of 71 patients who underwent curative gastrectomy for gastric cancer between November 2017 and April 2020. The patients underwent continuous glucose monitoring twiceāat 1- and 12-month postgastrectomyāand were assessed using the Post-Gastrectomy Syndrome Assessment Scale 37-item questionnaire (PGSAS-37) at 1-, 6-, and 12-month postgastrectomy. Results: Our results revealed that hypoglycemia (<70 mg/dL), especially nocturnal hypoglycemia (00:00ā06:00), frequently occurred even at 12-month postgastrectomy. Hypoglycemia improved in total gastrectomy patients but remained unchanged in distal gastrectomy patients, which was still high in both groups at 12-month postgastrectomy. Glycemic variability (SD of the glycemic trend) was exacerbated in both gastrectomy groups. However, the PGSAS-37 symptom scores remained unchanged, and the living status and quality of life tended to improve. Hypoglycemia unawareness, including postprandial hypoglycemia without symptoms and nocturnal hypoglycemia, was evident even 12-month postgastrectomy. Conclusions: Persistent postgastrectomy hypoglycemia unawareness, including late dumping syndrome without symptoms and nocturnal hypoglycemia, should be recognized as an important issue in postgastrectomy syndrome. Therefore, meticulous long-term evaluation for glycemic trends and care of patients is required.
- 23 February 2022
- Published byĀ Wolters Kluwer HealthĀ inĀ Annals of Surgery Open
- Vol.Ā 3 Ā (1) , e135
Open AccessPersistent Postgastrectomy Hypoglycemia Unawareness in Patients With Gastric Cancer Unveiled by a Prospective Study
Objective: Late dumping syndrome is a common postgastrectomy complication characterized by reactive hypoglycemia. This study aimed to explore the glycemic trend in patients who underwent gastrectomy for gastric cancer and clarify its changes over time in association with postgastrectomy symptoms. Summary Background Data: Changes over time in glycemic trend in association with postgastrectomy symptoms have not been evaluated. Methods: We conducted a prospective study of 71 patients who underwent curative gastrectomy for gastric cancer between November 2017 and April 2020. The patients underwent continuous glucose monitoring twiceāat 1- and 12-month postgastrectomyāand were assessed using the Post-Gastrectomy Syndrome Assessment Scale 37-item questionnaire (PGSAS-37) at 1-, 6-, and 12-month postgastrectomy. Results: Our results revealed that hypoglycemia (<70 mg/dL), especially nocturnal hypoglycemia (00:00ā06:00), frequently occurred even at 12-month postgastrectomy. Hypoglycemia improved in total gastrectomy patients but remained unchanged in distal gastrectomy patients, which was still high in both groups at 12-month postgastrectomy. Glycemic variability (SD of the glycemic trend) was exacerbated in both gastrectomy groups. However, the PGSAS-37 symptom scores remained unchanged, and the living status and quality of life tended to improve. Hypoglycemia unawareness, including postprandial hypoglycemia without symptoms and nocturnal hypoglycemia, was evident even 12-month postgastrectomy. Conclusions: Persistent postgastrectomy hypoglycemia unawareness, including late dumping syndrome without symptoms and nocturnal hypoglycemia, should be recognized as an important issue in postgastrectomy syndrome. Therefore, meticulous long-term evaluation for glycemic trends and care of patients is required.